(2019). Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study. Future Cardiol. http://doi.org/10.2217/fca-2019-0012
. R. Alikhan
First name
R.
Last name
Alikhan
(2019). Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study. TH Open. http://doi.org/10.1055/s-0039-1698413
. (2019). Impact of atrial fibrillation awareness campaigns: interrupted time series using the Clinical Practice Research Datalink. Future Cardiol. http://doi.org/10.2217/fca-2019-0025
. (2019). The changing face of venous thromboembolism management in England. Future Cardiol. http://doi.org/10.2217/fca-2019-0003
. (2019). Costs of gastrointestinal bleeding events in atrial fibrillation: a UK Clinical Practice Research Datalink study. Future Cardiol. http://doi.org/10.2217/fca-2019-0033
. (2019). Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin. J Comp Eff Res. http://doi.org/10.2217/cer-2019-0005
. (2020). Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study. Age Ageing. http://doi.org/10.1093/ageing/afaa045
.